Novartis to acquire Advanced Accelerator Applications for $3.9bn to enhance oncology portfolio

Novartis, the Switzerland-based global healthcare giant, has announced its decision to acquire Advanced Accelerator Applications (AAA), a French radiopharmaceutical company, for $3.9 billion. This acquisition ... Read More